SK
Sudhir Kumar Bhatta
About Sudhir Kumar Bhatta
Data last updated:
Sudhir Kumar Bhatta is a Director at Velesila Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Velesila Pharmaceuticals Private Limited reported revenue of ₹26.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Apr 2023 | 2023 | ₹26.1 Lakh (FY 2025) | Active |
Board colleagues of Sudhir Kumar Bhatta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Himanshu Mishra | 10116449 | Velesila Pharmaceuticals Private Limited | Director |
| Sunil Kumar Mishra | 10938387 | Velesila Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhir Kumar Bhatta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhir Kumar Bhatta
Sudhir Kumar Bhatta currently holds 1 directorship: Velesila Pharmaceuticals Private Limited (Director, since 17 Apr 2023, revenue ₹26.1 Lakh (FY 2025)).
Sudhir Kumar Bhatta was first appointed on 17 Apr 2023 as Director at Velesila Pharmaceuticals Private Limited.
The current boards of Sudhir Kumar Bhatta's companies include Himanshu Mishra (Velesila Pharmaceuticals Private Limited), Sunil Kumar Mishra (Velesila Pharmaceuticals Private Limited).